Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nephrology/Urology
Disease Category: Benign Prostatic Hyperplasia (Enlarged Prostate)
Trial Information
Phase 1 study of the Litx BPH System in patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia
Eligible patients will be enrolled into one of the two Litx treatment cohorts (A or B). Patients will undergo the procedure of Litx BPH Device placement into the prostate urethra.
Inclusion Criteria:
Males, 50 years or older who are on alpha blocker. Moderate to secer BPH bother score > 3. An IPSSs score of > 15.
Exclusion Criteria
Patients with an active urinary tract infection, evidence or history of prostate or bladder cancer.
Somar Macek, Study Coordinator
Integrity Medical Research, LLC
6005 244th St. SW #121
Mountlake Terrace, WA 98043
Phone: 425-275-0680
Fax: 425-275-0681
EMail: smacek@integritymedicalreasearch.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
